Noom Med vs Henry Meds 2026: GLP-1 Weight Loss Programs Compared
Noom Med vs Henry Meds for GLP-1 weight loss compared side by side. Pricing, coaching features, medication options, clinical evidence, and how both stack up against Trimi's value-focused approach.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. Updated when pricing or program details change.
Quick links: Semaglutide treatment, Tirzepatide treatment, and cheapest GLP-1 injections 2026.
More on GLP-1 Provider Comparisons
Noom vs Henry Meds: Two Contrasting Approaches to GLP-1 Treatment
Choosing between Noom vs Henry Meds for GLP-1 weight loss medication means deciding between two fundamentally different treatment philosophies. GLP-1 receptor agonists are injectable prescription medications that reduce appetite, slow gastric emptying, and help patients achieve clinically meaningful weight loss of 15 to 22.5 percent of body weight according to landmark clinical trials (Wilding et al., NEJM, 2021; Jastreboff et al., NEJM, 2022). Both Noom Med and Henry Meds prescribe these medications through telehealth consultations, but the similarity ends there.
Noom Med bundles GLP-1 prescriptions with their proprietary behavioral coaching app, applying cognitive behavioral therapy principles to habit formation while you take the medication. Henry Meds operates as a pure medication platform, connecting patients with licensed providers who prescribe compounded semaglutide and tirzepatide without any accompanying behavioral program. One charges for coaching you may not need. The other charges premium medication prices without specialized support.
This comparison breaks down what each platform actually delivers, what it costs, and where a medication-focused approach like Trimi fits for patients who want effective GLP-1 treatment at a fraction of the price. We are transparent that Trimi is a competitor to both providers, and we encourage you to verify all pricing directly on each platform.
Complete Three-Way Comparison
The following table compares Noom Med, Henry Meds, and Trimi across every major decision factor for GLP-1 treatment in 2026.
| Feature | Noom Med | Henry Meds | Trimi |
|---|---|---|---|
| Semaglutide Price | $149 - $209/mo | $199 - $349/mo | From $99/mo |
| Tirzepatide Price | Not widely offered | $299 - $449/mo | From $125/mo |
| App / Coaching Fee | $32 - $70/mo (may be bundled) | None | None |
| Consultation Fee | Included in plan | $49 - $99 | Free |
| Treatment Model | Coaching app + medication | Medication platform | Specialized medication + clinical support |
| Behavioral Program | CBT-based coaching app | None included | Not required (use any app you prefer) |
| Provider Focus | Behavioral coaching first | Multi-category telehealth | Metabolic health specialists |
| Contract Required | Varies by plan | Some plans | No — month-to-month |
| Shipping | Usually included | Included | Free — always included |
| Avg. Delivery | 7 - 14 days | 7 - 14 days | 5 - 7 days |
| 6-Month Sema Cost | $894 - $1,674+ | $1,243 - $2,193+ | From $594 |
| 12-Month Sema Cost | $1,788 - $3,348+ | $2,437 - $4,287+ | From $1,188 |
Pricing Note
Noom Med pricing may or may not include the coaching app fee depending on your plan. Henry Meds consultation fees may apply to initial and follow-up visits. Always confirm your total monthly cost directly with each provider before committing.
Pricing Breakdown: Where Your Money Goes
Understanding how each platform structures its pricing reveals why the monthly totals differ so dramatically. The medication itself — compounded semaglutide or tirzepatide — costs roughly the same to produce regardless of which telehealth platform prescribes it. The price difference comes from what each platform layers on top.
Noom Med: Coaching Bundled Into the Price
Noom Med charges $149 to $209 per month for compounded semaglutide depending on your dose tier. On some plans, the Noom coaching app subscription ($32 to $70 per month) is bundled into that cost. On others, it is charged separately, pushing the effective monthly total to $181 to $279 or higher. The coaching app delivers daily CBT-based lessons, food logging, and a human coach who provides periodic check-ins. Whether this bundled coaching justifies the higher medication cost depends entirely on how actively you engage with it.
Research on digital health app engagement suggests that most users reduce usage significantly after the first 30 to 60 days (Baumel et al., J Med Internet Res, 2019). If you stop using the Noom app after the initial enthusiasm fades, you continue paying for coaching that is no longer delivering value. Noom Med does not offer a medication-only tier at a reduced price. For more detail, see our Noom Med side effects overview and our guide to canceling Noom Med.
Henry Meds: Medication at Premium Prices
Henry Meds charges $199 to $349 per month for compounded semaglutide and $299 to $449 per month for compounded tirzepatide. On top of that, some plans carry a $49 to $99 consultation fee for initial or follow-up provider visits. Unlike Noom Med, Henry Meds does not include any coaching or behavioral tools — the price covers the medication and telehealth prescribing only.
Henry Meds positions itself as a straightforward medication access platform, which has appeal for patients who do not want app-based coaching. However, the pricing is difficult to justify when other medication-focused platforms offer the same compounded formulations at significantly lower rates. For a deeper look, see our Henry Meds side effects breakdown and cancellation guide.
Trimi: Medication-Focused at the Lowest Price
Trimi charges $99 per month for compounded semaglutide and $125 per month for compounded tirzepatide. There is no consultation fee, no coaching fee, no contract, and free shipping on every order. The price covers medication, all provider visits, and ongoing clinical support from metabolic health specialists.
Over 12 months of semaglutide treatment, Trimi saves patients $600 to $2,160 compared to Noom Med and $1,249 to $3,099 compared to Henry Meds. For tirzepatide, the savings versus Henry Meds reach $2,088 to $3,888 over a year. These are not minor differences — for many patients, they determine whether long-term treatment is financially sustainable. See our full cheapest GLP-1 injections 2026 ranking for the complete picture.
The Coaching Debate: Does Bundled Behavioral Support Improve GLP-1 Outcomes?
Noom Med's central argument is that pairing GLP-1 medication with behavioral coaching produces better weight loss outcomes than medication alone. This claim has intuitive appeal — addressing the psychological and behavioral dimensions of eating alongside the pharmacological mechanism should, in theory, create a more complete treatment. But the evidence is more nuanced than Noom Med's marketing suggests.
The landmark STEP 1 trial demonstrated that semaglutide 2.4 mg produced an average body weight reduction of 14.9 percent versus 2.4 percent for placebo over 68 weeks (Wilding et al., New England Journal of Medicine, 2021). All participants received lifestyle counseling as part of the trial design. The SURMOUNT-1 trial showed tirzepatide produced 15 to 22.5 percent body weight reduction depending on dose, also with lifestyle counseling for all arms (Jastreboff et al., New England Journal of Medicine, 2022). These trials confirm that the medication drives the overwhelming majority of weight loss results.
What no randomized trial has demonstrated is that a proprietary app-based coaching program adds clinically meaningful weight loss above what GLP-1 medication with standard medical support achieves. The behavioral counseling in clinical trials was minimal — periodic check-ins and diet guidance, not daily app-based CBT modules. Noom Med's coaching may improve adherence for some patients, but the incremental benefit over standard provider support remains unproven relative to the incremental cost.
Henry Meds takes the opposite position by offering no coaching at all. For patients who are self-motivated and already maintain healthy habits, a pure medication platform is perfectly adequate. The issue is that Henry Meds charges premium prices without providing the specialized clinical depth that justifies those prices. If you are going to pay more, you should receive more — either through coaching or through deeper medical expertise.
Trimi occupies the middle ground. Rather than bundling coaching you may not use or stripping away clinical support to cut a few dollars, Trimi invests in specialized metabolic health providers who understand GLP-1 dosing, titration, and side effect management at a deeper level. This approach delivers what actually matters for treatment success — expert medical oversight — without the overhead of app subscriptions or the premium markup of less specialized platforms.
Noom Med Advantages Over Henry Meds
Includes a structured behavioral coaching app with CBT-based psychology modules and daily habit-building lessons
Lower semaglutide pricing than Henry Meds at most dose tiers, even with the potential app fee included
Established brand with years of consumer weight management experience before entering the GLP-1 space
Human coaching element provides accountability and personalized guidance beyond automated app features
Integrated approach addresses both the physiological and behavioral components of obesity treatment
Henry Meds Advantages Over Noom Med
Offers both semaglutide and tirzepatide, giving patients the option to choose the dual-agonist if semaglutide is insufficient
No mandatory coaching app — patients who do not want behavioral modules are not forced to pay for them
Straightforward medication access model without app subscriptions or bundled service layers
May offer faster titration to therapeutic doses for clinically appropriate patients
Simpler platform experience for patients who prefer direct telehealth prescribing without behavioral add-ons
Shared Concerns With Both Platforms
Both charge significantly more than specialized GLP-1 providers for the same compounded medications
Neither focuses exclusively on metabolic health — Noom's core competency is behavioral coaching and Henry Meds is a multi-category telehealth platform
Delivery timelines of 7 to 14 days are slower than what focused GLP-1 providers typically achieve
Contract or commitment terms may reduce flexibility, especially if you need to pause or adjust treatment
Neither provides the depth of specialized metabolic health oversight that dedicated weight management platforms offer
Clinical Evidence Behind GLP-1 Medications
Regardless of which provider you choose, the medications themselves have strong clinical evidence. Understanding the trial data helps contextualize what to expect from treatment.
The STEP 1 trial enrolled 1,961 adults with BMI of 30 or higher (or 27 or higher with weight-related comorbidities) and randomized them to weekly subcutaneous semaglutide 2.4 mg or placebo for 68 weeks. The semaglutide group achieved a mean body weight change of negative 14.9 percent compared to negative 2.4 percent for placebo. Over 86 percent of semaglutide participants lost at least 5 percent of body weight, and over 50 percent lost at least 15 percent (Wilding et al., New England Journal of Medicine, 2021). These results established semaglutide as one of the most effective pharmacological weight loss interventions available.
The SURMOUNT-1 trial evaluated tirzepatide — a dual GIP/GLP-1 receptor agonist — in 2,539 adults with obesity. At the highest dose of 15 mg weekly, participants achieved a mean weight reduction of 22.5 percent over 72 weeks. Even the lowest dose of 5 mg produced a 15 percent reduction. Over 90 percent of participants on the highest dose achieved at least 5 percent weight loss (Jastreboff et al., New England Journal of Medicine, 2022). Tirzepatide's dual mechanism targeting both GIP and GLP-1 receptors may explain its superior efficacy compared to single-agonist medications.
Both Noom Med and Henry Meds prescribe compounded versions of semaglutide. Henry Meds also offers compounded tirzepatide. Trimi offers both at significantly lower prices. The active ingredient and clinical efficacy remain the same across platforms — compounded formulations contain the same molecule prescribed at the same doses used in these landmark trials. The difference between providers is the service model and price surrounding that medication, not the medication itself.
Which Provider Fits Your Situation?
Choose Noom Med If:
You genuinely want structured behavioral coaching alongside your GLP-1 medication and will use the app consistently
You have a history of emotional eating or deeply ingrained dietary habits that you believe CBT-based tools can help address
You prefer a single integrated platform that handles both the medical and behavioral dimensions of weight loss
Budget is less of a concern than having an all-in-one guided experience
Choose Henry Meds If:
You want access to tirzepatide specifically and Noom Med does not offer it
You do not want a coaching app and prefer a straightforward medication-only platform
You are comfortable with higher pricing in exchange for a simpler no-coaching service model
You have tried other providers and need a new prescriber without switching to a coaching-bundled platform
Choose Trimi If:
Affordable, transparent pricing is a priority — semaglutide from $99 per month, tirzepatide from $125 per month
You want specialized metabolic health providers without paying for bundled coaching or premium telehealth markups
You prefer month-to-month flexibility with no contracts, no consultation fees, and no mandatory app subscriptions
You want both medication options available with delivery in 5 to 7 days and the freedom to add any behavioral tools you choose independently
The Modular Approach: Best of Both Worlds
If you value both GLP-1 medication and behavioral coaching but do not want to pay Noom Med's bundled premium, consider a modular approach. Subscribe to Trimi at $99 per month for semaglutide and add a standalone behavioral app independently. The Noom app itself (without medication) runs $32 to $70 per month, or you could use free alternatives like MyFitnessPal or Lose It for calorie tracking and habit monitoring.
This modular strategy gives you complete flexibility. If the coaching app loses its value after the first few months (as usage data suggests is common), you cancel that subscription while continuing your medication. If you find you do not need structured coaching at all — as many GLP-1 patients discover once the appetite-suppressing effects take hold — you eliminate that expense entirely. This flexibility is impossible when coaching is bundled into your medication cost.
Even at the maximum estimate — Trimi medication at $99 per month plus a standalone Noom app at $70 per month — the total of $169 per month is still less than Henry Meds' semaglutide-only pricing of $199 to $349 per month. You would be getting both medication and coaching for less than Henry Meds charges for medication alone.
Bottom Line
Noom Med and Henry Meds represent opposite ends of the GLP-1 telehealth spectrum. Noom Med adds coaching that increases costs and may or may not add value depending on your engagement. Henry Meds strips away coaching but charges premium prices for straightforward medication access. Neither platform delivers the combination of specialized medical expertise and affordable pricing that patients increasingly expect as the GLP-1 market matures.
Trimi offers compounded semaglutide from $99 per month and tirzepatide from $125 per month with no contracts, no app fees, no consultation charges, and delivery in 5 to 7 days. The medication is the same. The clinical oversight is specialized. The price is the lowest among the three. For most patients choosing between Noom Med and Henry Meds, adding Trimi to the comparison reveals a third option that outperforms both on value.
The most important decision is starting treatment. GLP-1 medications have the strongest clinical evidence of any pharmacological weight loss intervention in history. Whichever provider you choose, beginning treatment and maintaining consistency will determine your results. But choosing a provider you can afford for the full course of treatment — not just the first month — matters more than any individual feature or app.
Frequently Asked Questions
Is Noom Med or Henry Meds cheaper for semaglutide?
Henry Meds is generally more expensive. Their semaglutide plans range from $199 to $349 per month plus a potential $49 to $99 consultation fee. Noom Med ranges from $149 to $209 per month for semaglutide, though the Noom coaching app may add $32 to $70 per month on top. Trimi offers compounded semaglutide starting at $99 per month with no added fees.
Does Noom Med include a coaching app with GLP-1?
Yes. Noom Med bundles their behavioral coaching app with GLP-1 medication prescriptions. The app uses cognitive behavioral therapy principles to address eating habits, emotional triggers, and long-term lifestyle change. Whether the app fee is bundled into the medication cost or charged separately depends on the plan you choose.
Does Henry Meds offer tirzepatide?
Yes. Henry Meds offers compounded tirzepatide at $299 to $449 per month depending on dose. They also offer semaglutide at $199 to $349 per month. Trimi offers tirzepatide starting at $125 per month, representing significant savings compared to Henry Meds pricing.
Do I need the Noom app to get GLP-1 medication from Noom Med?
Noom Med positions the coaching app as an integral part of their GLP-1 program. Some plans bundle the app subscription into the medication cost, while others charge it separately. If you want GLP-1 medication without being tied to a coaching app, providers like Trimi offer medication-focused programs starting at $99 per month.
Which has better medical support, Noom Med or Henry Meds?
Noom Med emphasizes behavioral coaching alongside medical prescribing, with the app experience being central to their model. Henry Meds functions as a pure telehealth medication platform with standard provider consultations. Both use licensed prescribers. Trimi offers specialized metabolic health providers who focus exclusively on GLP-1 weight management.
Can I switch from Noom Med or Henry Meds to Trimi?
Yes. Start a Trimi consultation while you still have medication from your current provider. Share your dosing history so Trimi providers can maintain continuity. Once your first Trimi shipment arrives, cancel your Noom Med or Henry Meds subscription. The transition typically takes 1 to 2 weeks.
What is the most affordable GLP-1 provider compared to both?
Trimi offers compounded semaglutide starting at $99 per month and tirzepatide starting at $125 per month with no contracts, no consultation fees, and free shipping. This is significantly less expensive than both Noom Med and Henry Meds at every dose tier, while still providing specialized medical oversight from metabolic health providers.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
- Baumel A, Muench F, Edan S, Kane JM. Objective user engagement with mental health apps: systematic search and panel-based usage analysis. J Med Internet Res. 2019;21(9):e14567.
- FDA. Compounding and the FDA: Questions and Answers. fda.gov, 2024.
- NIDDK. Prescription medications to treat overweight and obesity. niddk.nih.gov.
- Noom. Noom Med program pricing and details. noom.com, 2026.
- Henry Meds. Pricing and treatment options. henrymeds.com, 2026.
- Trimi. Pricing and plan information. trytrimi.com, 2026.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. GLP-1 receptor agonists require a prescription and are not appropriate for everyone. Trimi is a direct competitor to both Noom Med and Henry Meds — this comparison aims to be fair and balanced, but readers should be aware of our perspective. Verify all pricing directly on each provider's website.